GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theravance Biopharma Inc (STU:0TB) » Definitions » FFO per Share

Theravance Biopharma (STU:0TB) FFO per Share


View and export this data going back to 2017. Start your Free Trial

What is Theravance Biopharma FFO per Share?

FFO per Share only applies to REITs.


Theravance Biopharma Business Description

Traded in Other Exchanges
Address
901 Gateway Boulevard, South San Francisco, CA, USA, 94080
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).